Menasché P, Tronc F, Nguyen A, Veyssié L, Demirag M, Larivière J, Le Dref O, Piwnica A H, Bloch G
Department of Cardiovascular Surgery, Hôpital Lariboisière, Paris, France.
Ann Thorac Surg. 1994 Jun;57(6):1429-34; discussion 1434-5. doi: 10.1016/0003-4975(94)90096-5.
The ability of retrograde warm blood cardioplegia to preserve hypertrophied myocardium remains controversial. This two-part study was undertaken to address this question in patients subjected to aortic valve replacement for calcified aortic valve stenosis complicated with echocardiographically defined left ventricular hypertrophy. Part 1 was designed to assess the intraoperative patterns of myocardial oxidative metabolism in 20 patients in whom the severity of left ventricular hypertrophy was reflected by a mean (+/- standard error of the mean) myocardial mass index of 213 +/- 15 g/m2. After antegrade arrest, warm blood cardioplegia was continuously given through the coronary sinus at a flow rate of 200 +/- 5 mL/min. The use of a low-dilution cardioplegia delivery technique enabled us to keep hematocrit at 25.6% +/- 0.9% and the core temperature was allowed to drift to 32.7 +/- 0.2 degrees C. At the end of the arrest period, blood samples were simultaneously taken from inflow (coronary sinus catheter) and outflow (left coronary ostium) cardioplegia and assayed for blood gases, oxygen content and saturation and lactate. Part II was designed to compare the clinical outcomes of these 20 warm patients with those of 20 case-matched patients in whom a conventional hypothermic myocardial protection technique was used. The results of part I show that after an average arrest period of 72 +/- 4 minutes, the residual oxygen demand was still high as reflected by a percent oxygen extraction of 34.8% +/- 4.1%. This demand, however, was adequately met by the supply, as demonstrated by (1) the absence of transmyocardial acid production, (2) a negligible release (outflow minus inflow) of lactate (0.28 +/- 0.1 mmol/L), and (3) a high residual oxygen saturation (65.7% +/- 3.8%) in outflow cardioplegia. The results of part II show that the clinical outcomes of warm patients were overall good and not different from those of the cold group. We conclude that retrograde warm blood cardioplegia can adequately preserve hypertrophied myocardium by keeping its metabolism predominantly aerobic during aortic cross-clamping provided that measures are taken to optimize the determinants of the oxygen demand/supply ratio throughout. These measures include avoidance of left ventricular distention, immediate ablation of any recurring activity during arrest, maintenance of high retrograde flow rates, limitation of hemodilution, and uninterrupted mode of cardioplegia delivery.
逆行温血心脏停搏法对肥厚心肌的保护能力仍存在争议。本分为两部分的研究旨在探讨这一问题,研究对象为因钙化性主动脉瓣狭窄合并经超声心动图确诊的左心室肥厚而接受主动脉瓣置换术的患者。第一部分旨在评估20例患者术中的心肌氧化代谢模式,这些患者左心室肥厚的严重程度通过平均(±平均标准误差)心肌质量指数213±15 g/m²反映。顺行性心脏停搏后,以200±5 mL/min的流速通过冠状窦持续给予温血心脏停搏液。采用低稀释度心脏停搏液灌注技术使我们能够将血细胞比容维持在25.6%±0.9%,并允许核心温度降至32.7±0.2℃。在心脏停搏期结束时,同时从流入(冠状窦导管)和流出(左冠状动脉口)心脏停搏液中采集血样,检测血气、氧含量、饱和度和乳酸。第二部分旨在比较这20例温血心脏停搏患者与20例采用传统低温心肌保护技术的匹配患者的临床结局。第一部分的结果显示,在平均心脏停搏72±4分钟后,残余氧需求仍然较高,氧摄取百分比为34.8%±4.1%反映了这一点。然而,这种需求得到了供应的充分满足,表现为:(1)无跨心肌酸生成;(2)乳酸释放量(流出量减去流入量)可忽略不计(0.28±0.1 mmol/L);(3)流出心脏停搏液中的残余氧饱和度较高(65.7%±3.8%)。第二部分的结果显示,温血心脏停搏患者的临床结局总体良好,与低温组无差异。我们得出结论,逆行温血心脏停搏法可通过在主动脉阻断期间使肥厚心肌的代谢主要保持有氧状态来充分保护肥厚心肌,前提是采取措施优化整个氧供需比的决定因素。这些措施包括避免左心室扩张、在心脏停搏期间立即消除任何复发性活动、维持较高的逆行流速、限制血液稀释以及不间断的心脏停搏液灌注模式。